REFERENCES
- Blanco I, de Serres F, Janciauskiene S, Arbesü D, Fernández-Bustillo E, Cárcaba V, Nita I. Estimates of the prevalence and number of fibromyalgia syndrome patients and their alpha-1 antitrypsin phenotypic distribution in ten countires. J Musculoske Pain 2007; 15(4)9–23
- Russell I J. Alphal-antitrypsin deficiency in the fibromyalgia syndrome. J Musculoske Pain 2006; 14(3)1–3
- Blanco I, Canto H, de Serres F J., Bustillo E F., Rodríguez M C. Alpha-1-antitrypsin replacement therapy efficiently controls fibromyalgia symptoms in two PI ZZ alpha-1-antitrypsin deficiency patients. J Rheumatol 2004; 31(10)2082–2085
- Stoller J K., Snider G L., Brantly M L. American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168(7)818–855
- Russell I J. Is it my fibromyalgia, doctor?. J Musculoske Pain 2001; 9(1)1–5
- Giske L, Røe C, Knardahl S, Vøllestad N K. Pain and sympathoadrenal responses to dynamic exercise in women with the fibromyalgia syndrome. J Musculoske Pain 2007; 15(4)25–38
- Ellenberg S S., Eisenberger M A. An efficient design for phase III studies of combination chemotherapies. Cancer Treatment Reports 1985; 69: 1147–1154
- Smith D R., Leggat P A. Prevalence and distribution of musculoskeletal pain among Australian medical students. J Musculoske Pain 2007; 15(4)39–46
- Taskaynatan M A., Ozgul A, Ozdemir A, Tan A K., Kalyon T A. Effects of steroid iontophoresis and electrotherapy on bicipital tendonitis. J Musculoske Pain 2007; 15(4)47–54
- Ko G D., Whitmore S, Huang D, McDonald R. Effective pain palliation in fibromyalgia patients with botulinum toxin type-A: Case series of 25. J Musculoske Pain 2007; 15(4)55–66
- Chuang C-C, Chung W-Y, Shu C, Chen M-W. Pain assessment in musculoskeletal pain patients by heart rate variability. J Musculoske Pain 2007; 15(4)67–74